Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyPippa Corrie, Stephen Falk, Meg Finch-Jones et al.|The Lancet Oncology|2019Cited by 1.2k
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, John P. Neoptolemos, Paul Silcocks et al.|The Lancet Oncology|2014Cited by 374
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, John P. Neoptolemos, Daniel H. Palmer et al.|The Lancet Oncology|2017Cited by 73
Time From Colorectal Cancer Surgery to Adjuvant ChemotherapyMikail Gögenur, Niels Henrik Holländer, Andreas Weinberger Rosen et al.|JAMA Surgery|2024Cited by 14